MAPT and Alzheimer disease: In mice with streptozotocin-induced sporadic AD, significant improvements in cognitive function and spatial memory recovery, as well as a significant reduction in the inflammatory biomarker TNF-α, Aβ, and tau protein levels, were observed [114].